Menu
GeneBe

rs745704046

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PP3_StrongPP5

The NM_000071.3(CBS):c.457G>A(p.Gly153Arg) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 0)
Exomes 𝑓: 0.000012 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

CBS
NM_000071.3 missense

Scores

15
2
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:1

Conservation

PhyloP100: 5.09
Variant links:
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 1 uncertain in NM_000071.3
PP3
MetaRNN computational evidence supports a deleterious effect, 0.987
PP5
Variant 21-43065690-C-T is Pathogenic according to our data. Variant chr21-43065690-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 212846.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=1, Pathogenic=2}. Variant chr21-43065690-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CBSNM_000071.3 linkuse as main transcriptc.457G>A p.Gly153Arg missense_variant 6/17 ENST00000398165.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CBSENST00000398165.8 linkuse as main transcriptc.457G>A p.Gly153Arg missense_variant 6/171 NM_000071.3 P1P35520-1

Frequencies

GnomAD3 genomes
Cov.:
0
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000119
AC:
3
AN:
253030
Hom.:
1
Cov.:
0
AF XY:
0.0000149
AC XY:
2
AN XY:
133912
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000516
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000725
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
0
ExAC
AF:
0.00000874
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Classic homocystinuria Pathogenic:3Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Nov 19, 2021NM_000071.2(CBS):c.457G>A(G153R) is a missense variant classified as a variant of uncertain significance in the context of homocystinuria, CBS-related. G153R has been observed in cases with relevant disease (PMID: 21517828, 16167124, 30246729). Functional assessments of this variant are available in the literature (PMID: 20455263, 22267502, 32000841). G153R has been observed in population frequency databases (gnomAD: NFE <0.002%). In summary, there is insufficient evidence to classify NM_000071.2(CBS):c.457G>A(G153R) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. -
Likely pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsAug 10, 2023- -
Likely pathogenic, no assertion criteria providedclinical testingClinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)Apr 01, 2023- -
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 02, 2023The p.Gly153Arg variant in CBS has been reported in 1 individual severe hyperhomocysteinemia which was compound heterozygous with a pathogenic variant, and in 1 homozygous individual with homocystinuria which segregatred in an affected sibling (An 2013 PMID: 30246729, aidi 2012 PMID: 21517828). Biochemical examination in these individuals showed high plasma homocysteine levels (An 2013 PMID: 30246729, aidi 2012 PMID: 21517828), and in vitro functional studies support an impact to the protein (Mayfield 2012 PMID 22267502). The variant was absent in large population databases. It was reported in ClinVar (Variation ID 212846). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive homcystinuria. ACMG/AMP criteria applied: PM3, PS3, PM2_Supporting, PP1, PP3, PP4. -
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2023CBS: PM2, PM3, PP4:Moderate, PP3, PS3:Supporting -
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeNov 14, 2023This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 153 of the CBS protein (p.Gly153Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of CBS-related conditions (PMID: 21517828, 30246729). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 212846). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CBS function (PMID: 22267502; external communication). For these reasons, this variant has been classified as Pathogenic. -
Homocystinuria Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 09, 2017Variant summary: The CBS c.457G>A (p.Gly153Arg) variant involves the alteration of a conserved nucleotide that lies within the pyridoxal-phosphate dependent enzyme domain (InterPro). 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 1/156632 control chromosomes at a frequency of 0.0000064, which does not exceed the estimated maximal expected allele frequency of a pathogenic CBS variant (0.0030414). The variant has been reported in a Saudi Arabian family, where two affected patients were homozygous for the variant, which was inherited from unaffected consanguineous heterozygous parents (Zaidi_2012). Additionally, two functional studies in yeast suggest that the variant may impact protein function (Wei_2010, Mayfield_2012). Taken together, this variant is classified as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.56
Cadd
Pathogenic
31
Dann
Pathogenic
1.0
DEOGEN2
Pathogenic
1.0
D;D;D;D;.
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.82
D
M_CAP
Pathogenic
0.97
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
4.6
H;H;H;H;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-7.9
D;D;D;D;D
REVEL
Pathogenic
0.95
Sift
Uncertain
0.0090
D;D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D;D
Polyphen
1.0
D;D;D;D;.
Vest4
0.90
MutPred
0.88
Gain of MoRF binding (P = 0.0056);Gain of MoRF binding (P = 0.0056);Gain of MoRF binding (P = 0.0056);Gain of MoRF binding (P = 0.0056);Gain of MoRF binding (P = 0.0056);
MVP
0.94
MPC
1.2
ClinPred
1.0
D
GERP RS
4.7
Varity_R
0.98
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs745704046; hg19: chr21-44485800; COSMIC: COSV61441297; COSMIC: COSV61441297; API